Global market for DNA vaccines to reach $2.7 billion in 2019

August 25, 2014

The vaccine industry is rapidly changing from a mostly empirical approach to a rational design approach. Rapid developments in molecular biology, DNA synthesis and immunobiology enable rational design approaches. These new technologies allow pharmaceutical firms to discover and develop high-value vaccines for novel applications, creating a substantial new market opportunity.

BCC Research provides a detailed report on the DNA vaccines in its report, DNA Vaccines: Technologies and Global Markets. According to this report, the global market for DNA vaccines was valued at $243.7 million in 2013 and is expected to increase to $305.3 million by 2014-end. This is further estimated to reach $2.7 billion by 2019, registering a CAGR of 54.8% from 2014 through 2019.

RSS Feeds – Biotechnology

Use this report for, but not limited to, the following reasons:

  • Gain an overview of the global market for DNA vaccines and related technologies
  • Analyze global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019
  • Access details concerning delivery and synthesis technologies, the forces driving market growth, product formats, and market applications for these products
  • Obtain information most useful for biotechnology, DNA plasmid, gene therapy, DNA delivery, pharmaceutical, vaccine, animal health, and biodefense companies
  • Review profiles of leading companies in the field as well as updates to alliance, merger, and acquisition activity
SAMPLE FIGURE
GLOBAL VALUE OF DNA VACCINE MARKET BY APPLICATION, 2013–2019
($ MILLIONS)1406027309_BIO067B-0

Click here to order your copy of this report (or any of its chapters) or to download the report overview.

Advertisements